annual cash & cash equivalents:
$35.00M+$30.00M(+600.00%)Summary
- As of today (June 8, 2025), RXO annual cash & cash equivalents is $35.00 million, with the most recent change of +$30.00 million (+600.00%) on December 31, 2024.
- During the last 3 years, RXO annual cash & cash equivalents has risen by +$6.00 million (+20.69%).
- RXO annual cash & cash equivalents is now -64.29% below its all-time high of $98.00 million, reached on December 31, 2022.
Performance
RXO Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$16.00M-$19.00M(-54.29%)Summary
- As of today (June 8, 2025), RXO quarterly cash & cash equivalents is $16.00 million, with the most recent change of -$19.00 million (-54.29%) on March 31, 2025.
- Over the past year, RXO quarterly cash & cash equivalents has increased by +$9.00 million (+128.57%).
- RXO quarterly cash & cash equivalents is now -92.45% below its all-time high of $212.00 million, reached on June 1, 2022.
Performance
RXO quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RXO Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +600.0% | +128.6% |
| 3 y3 years | +20.7% | - |
| 5 y5 years | - | - |
RXO Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -64.3% | +600.0% | -92.5% | +220.0% |
| 5 y | 5-year | -64.3% | +600.0% | -92.5% | +220.0% |
| alltime | all time | -64.3% | +600.0% | -92.5% | +220.0% |
RXO Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $16.00M(-54.3%) |
| Dec 2024 | $35.00M(+600.0%) | $35.00M(-36.4%) |
| Sep 2024 | - | $55.00M(+685.7%) |
| Jun 2024 | - | $7.00M(0.0%) |
| Mar 2024 | - | $7.00M(+40.0%) |
| Dec 2023 | $5.00M | $5.00M(-95.2%) |
| Sep 2023 | - | $104.00M(-16.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $124.00M(+2.5%) |
| Mar 2023 | - | $121.00M(+23.5%) |
| Dec 2022 | $98.00M(+237.9%) | $98.00M(-47.6%) |
| Sep 2022 | - | $187.00M(-11.8%) |
| Jun 2022 | - | $212.00M(+631.0%) |
| Dec 2021 | $29.00M(-58.6%) | - |
| Dec 2021 | - | $29.00M |
| Dec 2020 | $70.00M | - |
FAQ
- What is RXO annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for RXO?
- What is RXO annual cash & cash equivalents year-on-year change?
- What is RXO quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for RXO?
- What is RXO quarterly cash & cash equivalents year-on-year change?
What is RXO annual cash & cash equivalents?
The current annual cash & cash equivalents of RXO is $35.00M
What is the all time high annual cash & cash equivalents for RXO?
RXO all-time high annual cash & cash equivalents is $98.00M
What is RXO annual cash & cash equivalents year-on-year change?
Over the past year, RXO annual cash & cash equivalents has changed by +$30.00M (+600.00%)
What is RXO quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of RXO is $16.00M
What is the all time high quarterly cash & cash equivalents for RXO?
RXO all-time high quarterly cash & cash equivalents is $212.00M
What is RXO quarterly cash & cash equivalents year-on-year change?
Over the past year, RXO quarterly cash & cash equivalents has changed by +$9.00M (+128.57%)